Company: XTIA
Filing Date: 2025-06-25
Form Type: 424B4
Source: 0001213900-25-057901
Chunk: 47

Company: XTI Aerospace, Inc.
Filing Date: 2025-06-25
Form: 424B4
Chunk 47
---
,143,000 |
| Total           |     |           | 6,231,200 |     |            | 2,911,800 |     |           | 9,143,000 |

The underwriters are committed
to purchase all the shares of common stock (and/or Pre-funded Warrants in lieu thereof) and Common Warrants offered by the Company. The
obligations of the underwriters may be terminated upon the occurrence of certain events specified in the underwriting agreement. Furthermore,
the underwriting agreement provides that the obligations of the underwriters to pay for and accept delivery of the shares offered by us
in this prospectus are subject to various representations and warranties and other customary conditions specified in the underwriting
agreement, such as receipt by the underwriters of officers’ certificates and legal opinions.

We have agreed to indemnify
the underwriters against specified liabilities, including liabilities under the Securities Act, and to contribute to payments the underwriters
may be required to make in respect thereof.

The underwriters are offering
the shares of common stock (and/or Pre-funded Warrants in lieu thereof) and Common Warrants subject to prior sale, when, as and if issued
to and accepted by them, subject to approval of legal matters by their counsel and other conditions specified in the underwriting agreement.
The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part.

We have granted the Representative
an over-allotment option. This option, which is exercisable for up to 45 days after the date of this prospectus, permits the underwriters
to purchase up to an aggregate of 1,371,000 additional shares of common stock (and/or Pre-funded Warrants in lieu thereof) and/or up to
an aggregate of 1,371,000 additional Common Warrants (equal to 15% of the total number of shares of common stock and/or Pre-funded Warrants
and/or 15% of the number of Common Warrants sold in this Offering, or any combination thereof). The purchase price of the shares sold
upon exercise of the over-allotment option shall be the public offering price per share less $0.01 per share; the purchase price of the
Pre-funded Warrants sold upon exercise of the over-allotment shall be the public offering price of the Pre-funded Warrants less $0.01
per Pre-funded Warrant; and the purchase price per Common Warrant shall be $